ALL THE LATEST STEM CELL RESEARCH, CORD BLOOD BANKING, ADULT STEM CELLS, STEM CELL THERAPY, REGENERATIVE MEDICINE AND MEDICAL SCIENCE NEWS IN MALAYSIA & THE REST OF THE WORLD.
Friday, May 15, 2009
In-vitro differentiation study on isolated human mesenchymal stem cells in Malaysia
Mesenchymal stem cells are pluripotent progenitors that could be found in human bone marrow. Mesenchymal stem cells are capable of renewing themselves without differentiation in long-term culture. These cells also have low immunogenicity and can suppress alloreactive T cell responses. In the current study, mesenchymal stem cells isolated and propagated previously from the bone marrow of a megaloblastic anaemia patient were tested for their capabilities to differentiate into adipocytes, chondrocytes and osteoblasts in vitro.
The differentiated cells were determined by Oil Red O, Alcian Blue-PAS and Alizarin Red S staining, and reverse transcriptase-polymerase chain reaction to determine the expression of mRNA specific for adipogenesis, chondrogenesis and osteogenesis. The results showed that the fibroblast-like cells were capable of differentiating into adipocytes, chondrocytes and osteoblasts upon chemical induction. The adipocytes, chondrocytes and osteoblasts were stained positively to Oil Red O, Alcian Blue-PAS and Alizarin Red S respectively.
The differentiated cells were also found to express mRNA specific for adipogenesis (‘peroxisome proliferation-activated receptor γ2’ and lipoprotein lipase), chondrogenesis (collagen type II) and osteogenesis (osteocalcin, osteopontin and alkaline phosphatase). In conclusion, this research has successfully isolated fibroblast-like cells from human bone marrow and these cells demonstrated morphological, cytochemical and immunochemical characteristics similar to mesenchymal stem cells. These cells maintain their proliferative properties and could be differentiated into the mesoderm lineage.
The success of this study is vital because mesenchymal stem cells can be used in cellular therapy to regenerate or replace damaged tissues, or as a vehicle for therapeutic gene delivery in the future.
Source: Mok, P.L., and Cheong, S.K., and Leong, C.F., (2008) In-vitro differentiation study on isolated human mesenchymal stem cells. Malaysian Journal of Pathology, 30 (1). pp. 11-19. ISSN 0126-8635
Our Supporting Partner - StemTECH International Sdn Bhd is dedicated and committed to cord blood and adult stem cell banking (collection/harvesting,procesing and storage), stem cell medical therapy, as well as R & D for the purpose of future stem cell technology, improvements, medical therapy and overall betterment of everyone. StemTECH International offers all Malaysians a personalised service with cutting-edge technologies and the most secured facilities available in this region.
Quote from StemTECH International... "We believe that cord blood stem cell banking should be made available to each and every newborn. For this reason, and placing medical interest ahead of commercial interest, we constantly strive to provide high quality service with our cutting-edge laboratory facilities giving the best value to all who demands it!" StemTECH International's Person In Charge is Professor Dr Menaka